Real-time enrollment status for this arrhythmogenic right ventricular cardiomyopathy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:42 AM UTC
| NCT Number | NCT06228924 |
| Recruiting Status | Recruiting |
| Condition | Arrhythmogenic Right Ventricular Cardiomyopathy |
| Phase | Clinical Trial |
| Target Enrollment | 15 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Tenaya Therapeutics |
| Last Updated on CT.gov | February 6, 2025 (Feb 6, 2025) |
As of July 13, 2026: Clinical trial NCT06228924 is currently recruiting participants. This clinical trial study for arrhythmogenic right ventricular cardiomyopathy is actively seeking new participants at 7 locations across the United States. The study is sponsored by Tenaya Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06228924 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06228924 was last updated Feb 6, 2025 (February 6, 2025). HelloStudys verifies this status automatically.